首页> 外国专利> HUMAN POLYPEPTIDES RELATED TO THE VANILLOID AND TRP FAMILIES OF CATION CHANNEL PROTEINS AND NUCLEIC ACIDS ENCODING THEM

HUMAN POLYPEPTIDES RELATED TO THE VANILLOID AND TRP FAMILIES OF CATION CHANNEL PROTEINS AND NUCLEIC ACIDS ENCODING THEM

机译:与阳离子通道蛋白和编码它们的核酸的香草醛和TRP家族有关的人类多肽

摘要

The present invention relates to novel human nucleic acid molecules encoding novel human cation channels, and proteins and polypeptides encoded by such nucleic acid molecules. More specifically, the nucleic acid molecules of the invention include novel human genes, e.g., hCCh3.1, hCCh3.2, and hCCh4, that encode proteins or polypeptides that display some sequence homology and structural homology to the vanilloid and TRP (transient receptor potential) families of cation channel proteins. The proteins and polypeptides of the invention represent novel cation channels that may be therapeutically valuable targets for drug delivery in the treatment of human diseases which involve calcium, sodium, potassium or other ionic homeostatic dysfunction, such as central nervous system (CNS) disorders, e.g., stroke or degenerative neurological disorders such as Alzheimer's disease, or other disorders such as cardiac disorders, e.g., arrhythmia, diabetes, chronic pain, hypercalcemia, hypocalcemia, hypercalciuria, hypocalciuria, or ion disorders associated with renal or liver disease.
机译:本发明涉及编码新型人阳离子通道的新型人核酸分子,以及由此类核酸分子编码的蛋白质和多肽。更具体地,本发明的核酸分子包括新的人类基因,例如hCCh3.1,hCCh3.2和hCCh4,其编码与类香草醇和TRP(瞬时受体电位)表现出某些序列同源性和结构同源性的蛋白质或多肽。 )阳离子通道蛋白家族。本发明的蛋白质和多肽代表新的阳离子通道,其可以是在治疗涉及钙,钠,钾或其他离子稳态功能障碍例如中枢神经系统(CNS)疾病的人类疾病中的药物递送的治疗上有价值的靶标。 ,中风或变性神经系统疾病(例如阿尔茨海默氏病)或其他疾病(例如心脏疾病),如心律不齐,糖尿病,慢性疼痛,高钙血症,低钙血症,高钙尿,低钙尿或与肾脏或肝脏疾病相关的离子性疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号